Gudrun M. Asgrimsdottir

VP of Pharmaceutical Development & Iceland Site & Lab Head at Oculis

Gudrun M. Asgrimsdottir joined Oculis in 2010 from GlaxoSmithKline in Reykjavik where she served as Business Unit Manager. Since joining Oculis, Ms. Asgrimsdottir has had management roles, currently holding the position of VP Pharmaceutical Development. Ms. Asgrimsdottir received a M.Sc. degree in pharmacy from the University of Iceland in 1997. Upon completing her studies, Ms. Asgrimsdottir joined the R&D department of Omega Farma ehf. where she was primarily responsible for analytical method development. In year 2000 she worked for GlaxoWellcome in the UK. Ms. Asgrimsdottir had the role of a clinical pharmacist in the UK for 4 years and did a diploma in hospital pharmacy from University of London in 2004. Ms. Asgrimsdottir is a co-author of 8 published papers in peer reviewed journals.

Links


Org chart


Teams


Offices

This person is not in any offices


Oculis

1 followers

Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.


Industries

Employees

11-50

Links